Nations Financial Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08M Sell
6,835
-700
-9% -$94.6K 0.05% 359
2026
Q1
$962K Sell
7,535
-1,200
-14% -$150K 0.05% 378
2025
Q4
$1.07M Buy
8,735
+4,875
+126% +$559K 0.06% 343
2025
Q3
$387K Sell
3,860
-25,384
-87% -$2.29M 0.02% 538
2025
Q2
$2.43M Sell
29,244
-252
-0.9% -$20.1K 0.17% 151
2025
Q1
$2.39M Sell
29,496
-441
-1% -$39.4K 0.18% 147
2024
Q4
$2.7M Sell
29,937
-426
-1% -$41.3K 0.2% 129
2024
Q3
$3M Buy
30,363
+372
+1% +$36.5K 0.22% 111
2024
Q2
$2.78M Buy
29,991
+324
+1% +$29K 0.23% 109
2024
Q1
$2.82M Sell
29,667
-489
-2% -$45.4K 0.24% 103
2023
Q4
$2.69M Sell
30,156
-295
-1% -$21.9K 0.25% 98
2023
Q3
$2.22M Sell
30,451
-416
-1% -$33.2K 0.22% 111
2023
Q2
$2.57M Buy
30,867
+102
+0.3% +$8.53K 0.25% 98
2023
Q1
$2.34M Buy
30,765
+25,686
+506% +$2.13M 0.25% 105
2022
Q4
$422K Sell
5,079
-100
-2% -$8.1K 0.05% 391
2022
Q3
$411K Buy
5,179
+100
+2% +$8.43K 0.06% 335
2022
Q2
$377K Buy
5,079
+60
+1% +$4.5K 0.05% 361
2022
Q1
$451K Buy
+5,019
New +$463K 0.05% 337
2021
Q1
Sell
-1,484
Closed -$209K 369
2020
Q4
$209K Buy
+1,484
New +$190K 0.06% 309
2020
Q3
Sell
-1,991
Closed -$223K 298
2020
Q2
$223K Buy
+1,991
New +$196K 0.08% 245

Other funds holding XBI

Nations Financial Group's XBI Position: Q2 2026 in Review

Nations Financial Group reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 9.3% in Q2 2026, selling an estimated $94.6K and leaving 6,835 shares worth $1.08M. The position accounts for 0.05% of the portfolio, ranked #359.

Nations Financial Group first reported a position in XBI in Q2 2020 and has held it in 20 quarters since. The position peaked at $3M in Q3 2024. 254 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Nations Financial Group held 6,835 shares of State Street SPDR S&P Biotech ETF worth $1.08M as of Q2 2026.
  • Nations Financial Group sold 700 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $94.6K.
  • State Street SPDR S&P Biotech ETF made up 0.05% of Nations Financial Group's portfolio in Q2 2026, its #359 holding.
  • Nations Financial Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and has held it in 20 quarters since.
  • Nations Financial Group's State Street SPDR S&P Biotech ETF position peaked at $3M in Q3 2024.
  • 254 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Nations Financial Group's 13F filing for Q2 2026, filed 23 Jul 2026.